合作伙伴

合作伙伴
CEVHAP对下列慷慨解囊之善士皆表诚衷感激:

Advocomm Singapore Pte Ltd
www.advocomm-sg.com

American Association for the Study of Liver Diseases
www.aasld.org

Asian Pacific Association for the Study of the Liver (APASL)
www.apasl.info

Australian Research Centre in Sex, Health and Society at La Trobe University
www.latrobe.edu.au

Australasian Society for HIV Medicine
www.ashm.org.au

Centers for Disease Control and Prevention, USA
www.cdc.gov

European Association for the Study of the Liver
www.easl.eu

Fleishman-Hillard, Asia Pacific
www.fleishman.com.hk

Golin Harris (Taiwan)
www.golinharris.com

Hepatitis B Foundation, USA
www.hepb.org

Korean Association for the Study of the Liver
www.kasl.org/english/introduction.htm

Kromite
www.kromite.com

Victorian Infectious Diseases Reference Laboratory (VIDRL)
www.vidrl.org.au

World Hepatitis Alliance (WHA)
www.worldhepatitisalliance.org

World Health Organisation (WHO)
www.who.int

药历网
www.yaoliwang.com

捐赠及赞助者

CEVHAP将捐赠及赞助金额分为三个等级。该款项将用于本联盟发起之针对病毒性肝炎之政策研究项目,相关延展研究及相关必要实践操作。

金钻善士 (每年贰拾万美金或以上)

bms logo msd logo

银钻善士 (每年拾万至贰拾万美金)

gilead logo

铜钻善士 (每年伍万至拾万美金)

Jassen

CEVHAP竭诚欢迎所有诚善捐助,共同致力降低病毒性肝炎与亚太地区所致之弊。

FaLang translation system by Faboba

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU

CAF badge

CEVHAP has been vetted and approved to receive tax-deductible donations and grants via CAF America.

If you are a US donor wishing to make a tax-deductible contribution to support us, please visit the “Give Now” page at CAF America’s website at www.cafamerica.org and following these steps:

1. Visit https://cafamerica.org

2. Click “Give Now”

3. “Give a single gift”

4. “Search and Give to organizations in the CAF America Database”

5. Type in “CEVHAP”

6. Click “Donate Now”

7. Fill out the form accordingly and click Submit

8. Enter credit card information and click Submit

9. Wait for the confirmation page – do not re-click submit or refresh the page as you may be additionally charged.

10. An e-mail confirmation will be sent to you for tax deduction purposes.

 

CEVHAP Activity Report Brochure EMAIL smaller Cover

>> 基本概况
病毒性肝炎
全球约有20亿乙肝病毒(HBV)携带者。
由该病毒所致之急性或慢性肝病,平均每
年夺取约60万人生命
如果未经有效治疗,患慢性丙肝及其他
进展性肝病(如肝硬化)之患者比例至2015
年将大幅提升百分之三十八。
目前并无丙肝预防疫苗问世,但约80%
患者可经有效针对性治疗而获痊愈
世界肝炎日 7月28 日
world hepatitis day-cn

世界卫生大会通过有关病毒性肝炎的

决议(WHA63.18),首次将病毒性肝炎

确认为全球性医疗议题,并确立每年

728日为世界肝炎日>>更多信息

>> 视频录影资料
病毒性肝炎所致之全球性健康危害

CEVHAP主席陈定信教授

Connect with usconnect with CEVHAP